Candesartan vs Tofacitinib

Candesartan vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Candesartan and Tofacitinib.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6; Tofacitinib — C16H20N6O.

Molecular Weight: Candesartan — 610.6640 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Candesartan — Small molecule; Tofacitinib — Small molecule.